Have a feature idea you'd love to see implemented?
Let us know!
NEPH Nephros Inc
Price (delayed)
$1.4899
Market cap
$15.71M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$0.13
Enterprise value
$14.21M
Nephros is a leading water technology company in medical and commercial water purification and pathogen detection, headquartered in the USA. Its diverse team of passionate employees are dedicated to advancing
Highlights
Nephros's net income has soared by 74% YoY and by 10% from the previous quarter
The EPS has soared by 72% YoY and by 7% from the previous quarter
The company's debt has surged by 84% YoY but it fell by 8% QoQ
The revenue has grown by 13% YoY but it has contracted by 2.1% from the previous quarter
The company's quick ratio fell by 46% YoY and by 4.9% QoQ
Nephros's equity has decreased by 8% YoY and by 3.1% QoQ
Key stats
What are the main financial stats of NEPH
Market
Valuations
Earnings
Shares outstanding
10.54M
Market cap
$15.71M
Enterprise value
$14.21M
Price to earnings (P/E)
N/A
Price to book (P/B)
1.98
Price to sales (P/S)
1.14
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
1.03
Revenue
$13.77M
EBIT
-$1.29M
EBITDA
-$1.12M
Free cash flow
-$923,000
Per share
Balance sheet
Liquidity
EPS
-$0.13
Free cash flow per share
-$0.09
Book value per share
$0.75
Revenue per share
$1.31
TBVPS
$0.93
Total assets
$11.1M
Total liabilities
$3.17M
Debt
$1.58M
Equity
$7.93M
Working capital
$5.97M
Debt to equity
0.2
Current ratio
4.06
Quick ratio
2.54
Net debt/EBITDA
1.34
Margins
Efficiency
Dividend
EBITDA margin
-8.1%
Gross margin
60.4%
Net margin
-9.4%
Operating margin
-9.9%
Return on assets
-11.4%
Return on equity
-15.6%
Return on invested capital
-23.4%
Return on capital employed
-14.1%
Return on sales
-9.4%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
NEPH stock price
How has the Nephros stock price performed over time
Intraday
-0.67%
1 week
-5.1%
1 month
-20.75%
1 year
-10.25%
YTD
-56.94%
QTD
-12.87%
Financial performance
How have Nephros's revenue and profit performed over time
Revenue
$13.77M
Gross profit
$8.31M
Operating income
-$1.37M
Net income
-$1.29M
Gross margin
60.4%
Net margin
-9.4%
The company's net margin has surged by 77% YoY and by 8% QoQ
Nephros's net income has soared by 74% YoY and by 10% from the previous quarter
The operating margin has soared by 55% YoY and by 7% QoQ
The company's operating income rose by 50% YoY and by 8% QoQ
Growth
What is Nephros's growth rate over time
Valuation
What is Nephros stock price valuation
P/E
N/A
P/B
1.98
P/S
1.14
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
1.03
The EPS has soared by 72% YoY and by 7% from the previous quarter
NEPH's price to book (P/B) is 61% less than its 5-year quarterly average of 5.1 and 32% less than its last 4 quarters average of 2.9
Nephros's equity has decreased by 8% YoY and by 3.1% QoQ
The price to sales (P/S) is 75% lower than the 5-year quarterly average of 4.5 and 33% lower than the last 4 quarters average of 1.7
The revenue has grown by 13% YoY but it has contracted by 2.1% from the previous quarter
Efficiency
How efficient is Nephros business performance
The ROS has soared by 77% YoY and by 8% from the previous quarter
The ROE has soared by 77% YoY and by 8% from the previous quarter
Nephros's ROIC has soared by 76% YoY and by 17% from the previous quarter
The return on assets has surged by 75% year-on-year and by 12% since the previous quarter
Dividends
What is NEPH's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for NEPH.
Financial health
How did Nephros financials performed over time
The total liabilities has soared by 83% YoY
The company's quick ratio fell by 46% YoY and by 4.9% QoQ
The company's debt is 80% lower than its equity
The debt to equity has surged by 100% year-on-year but it has declined by 4.8% since the previous quarter
The company's debt has surged by 84% YoY but it fell by 8% QoQ
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.